Eli Lilly and Co Newsroom

Eli Lilly's Zepbound Receives FDA Approval For Obesity-Linked Sleep Apnea Drug

Benzinga23:48 ET

Eli Lilly and Co's Zepbound has been approved by the FDA for the treatment of obstructive sleep apnea.

① The FDA in the USA approved Eli Lilly and Co's weight loss medication Zepbound on Friday for the treatment of obstructive sleep apnea (OSA), making it the first drug approved for directly treating this common sleep disorder; ② The active ingredient in Zepbound is Tirzepatide, which was initially used to treat type 2 diabetes, namely Eli Lilly and Co's Mounjaro.

cls.cn15:45 ET

Trending Stocks in Bearish Pre-holiday Week for U.S. Stock Market

Seeking AlphaDec 21 10:58 ET

Novo Nordisk Raises Expectations for Eli Lilly After CagriSema Slipup

Seeking AlphaDec 21 10:03 ET

Citi Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Raises Target Price to $1,250

Moomoo NewsDec 21 05:33 ET · Ratings

Did Novo-Nordisk A/S fall, leaving Eli Lilly and Co to dominate the weight loss medication market?

Novo-Nordisk A/S faced a "Waterloo," with new drug effects falling short of expectations, causing a dramatic drop in stock prices. The landscape of the weight loss drug market is quietly changing; will Eli Lilly and Co become a sole oligopoly?

wallstreetcnDec 21 02:50 ET

News Highlights: Top Company News of the Day - Friday at 7 PM ET

Dow JonesDec 20 19:00 ET

Novo Nordisk Stock Crashes on Obesity Drug Data. It's a Win for Eli Lilly. -- Barrons.com

Barron'sDec 20 17:58 ET

FDA Approves First Medication for Obstructive Sleep Apnea

PR NewswireDec 20 17:39 ET

Eli Lilly Says FDA Approves Zepbound for Obstructive Sleep Apnea in Adults With Obesity

WSJDec 20 16:51 ET

Eli Lilly and Co Options Spot-On: On December 20th, 78,637 Contracts Were Traded, With 362.35K Open Interest

Moomoo NewsDec 20 16:30 ET

Express News | US FDA Approves Eli Lilly's Zepbound for Moderate-to-Severe Obstructive Sleep Apnea in Adults With Obesity - Website

ReutersDec 20 16:25 ET

Stocks to Watch Friday: Trump Media, Novo Nordisk, Eli Lilly, Tesla -- WSJ

WSJDec 20 16:23 ET

Sector Update: Health Care Stocks Rise in Late Afternoon Trading

MT NewswiresDec 20 15:57 ET

Pfizer Gets FDA Accelerated Approval for Braftovi

Seeking AlphaDec 20 15:36 ET

Sector Update: Health Care

MT NewswiresDec 20 15:27 ET

Jefferies Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $994

Moomoo NewsDec 20 13:31 ET · Ratings

Leerink Partners Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Announces Target Price $970

Moomoo NewsDec 20 13:31 ET · Ratings

Bernstein Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,100

Moomoo NewsDec 20 13:31 ET · Ratings

There's a New Obesity King -- Heard on the Street -- WSJ

WSJDec 20 13:07 ET